Victory Capital Management Inc. Buys 49,701 Shares of Viemed Healthcare, Inc. (NASDAQ:VMD)

Key Points

• Victory Capital Management Inc. has increased its stake in Viemed Healthcare, Inc. by 45.8%, now owning approximately 0.40% of the company valued at $1.15 million.
• Multiple institutional investors, including Divisadero Street Capital Management and JPMorgan Chase & Co., have significantly increased their holdings in Viemed during the fourth quarter.
• Viemed Healthcare reported quarterly earnings of $0.06 EPS, meeting expectations, with a revenue of $59.1 million despite missing analyst estimates.

Victory Capital Management Inc. raised its position in Viemed Healthcare, Inc. (NASDAQ:VMD - Free Report) by 45.8% during the 1st quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 158,198 shares of the company's stock after buying an additional 49,701 shares during the quarter. Victory Capital Management Inc. owned about 0.40% of Viemed Healthcare worth $1,152,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors also recently made changes to their positions in VMD. Millennium Management LLC acquired a new position in shares of Viemed Healthcare in the 4th quarter worth approximately $573,000. Ameriprise Financial Inc. acquired a new position in shares of Viemed Healthcare in the 4th quarter worth approximately $340,000. Nuveen Asset Management LLC lifted its position in shares of Viemed Healthcare by 22.1% in the 4th quarter. Nuveen Asset Management LLC now owns 162,272 shares of the company's stock worth $1,301,000 after purchasing an additional 29,320 shares during the period. Arrowstreet Capital Limited Partnership acquired a new position in shares of Viemed Healthcare in the 4th quarter worth approximately $1,549,000. Finally, Northern Trust Corp lifted its position in shares of Viemed Healthcare by 1.8% in the 4th quarter. Northern Trust Corp now owns 286,818 shares of the company's stock worth $2,300,000 after purchasing an additional 5,090 shares during the period. 74.24% of the stock is owned by institutional investors.

Viemed Healthcare Stock Down 2.6%

Shares of Viemed Healthcare stock traded down $0.16 during trading on Friday, reaching $5.93. 296,959 shares of the company traded hands, compared to its average volume of 220,438. The company has a debt-to-equity ratio of 0.03, a current ratio of 1.38 and a quick ratio of 1.26. Viemed Healthcare, Inc. has a 1-year low of $5.93 and a 1-year high of $9.81. The company has a 50 day moving average price of $6.67 and a 200-day moving average price of $7.13. The firm has a market capitalization of $234.35 million, a PE ratio of 19.77 and a beta of 1.34.

Viemed Healthcare (NASDAQ:VMD - Get Free Report) last released its earnings results on Wednesday, May 7th. The company reported $0.06 earnings per share (EPS) for the quarter, meeting analysts' consensus estimates of $0.06. Viemed Healthcare had a net margin of 5.28% and a return on equity of 9.49%. The company had revenue of $59.10 million for the quarter, compared to the consensus estimate of $60.60 million.

Insider Activity

In other Viemed Healthcare news, Director Nitin Kaushal sold 34,100 shares of the company's stock in a transaction on Friday, June 27th. The shares were sold at an average price of $7.01, for a total transaction of $239,041.00. Following the transaction, the director owned 126,843 shares in the company, valued at approximately $889,169.43. This represents a 21.19% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. 20.00% of the stock is owned by insiders.

About Viemed Healthcare

Viemed Healthcare, Inc, together with its subsidiaries, provides home medical equipment (HME) and post-acute respiratory healthcare services to patients in the United States. It provides respiratory disease management solutions, including treatment of chronic obstructive pulmonary disease (COPD), which include non-invasive ventilation, percussion vests, and other therapies; and invasive and non-invasive ventilation and related equipment and supplies to patients suffering from COPD.